Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This Clinical Trial is being conducted to study Hypophosphatasia (HPP), a bone disorder caused by gene mutations or changes. These gene mutations cause low levels of an enzyme needed to harden bone. The purpose of this study is to test the safety of the study drug called ENB-0040 and see what effects is has on human juveniles and HPP.
Epistemonikos ID: 89f58b46e078b9d5ebd18cb84b2709fa01e3f33b
First added on: May 05, 2024